tiprankstipranks
BeOne Medicines (ONC)
NASDAQ:ONC
US Market
ONC
BeOne Medicines
RESEARCH TOOLSreports

BeOne Medicines (ONC) Stock News & Sentiment

859 Followers
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
Premium
Ratings
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
10d ago
ONC
BeOne Medicines Advances Combo Cancer Pill With Completed Phase 1 Bioavailability Study
Premium
Company Announcements
BeOne Medicines Advances Combo Cancer Pill With Completed Phase 1 Bioavailability Study
11d ago
ONC
BeOne Medicines Advances BG-A3004 Into First-in-Human Skin Disease Trial: What Investors Should Watch
Premium
Company Announcements
BeOne Medicines Advances BG-A3004 Into First-in-Human Skin Disease Trial: What Investors Should Watch
17d ago
ONC
Early Cancer Drug Trial Termination Highlights Pipeline Risk for BeOne Medicines (ONC)
Premium
Company Announcements
Early Cancer Drug Trial Termination Highlights Pipeline Risk for BeOne Medicines (ONC)
20d ago
ONC
BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors
Premium
Company Announcements
BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors
23d ago
ONC
Beigene, Ltd. (ONC) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Beigene, Ltd. (ONC) Q4 Earnings Cheat Sheet
1M ago
ONC
Zanubrutinib Update: What BeiGene’s BTK Intolerance Study Means for Oncology Investors
Premium
Company Announcements
Zanubrutinib Update: What BeiGene’s BTK Intolerance Study Means for Oncology Investors
2M ago
ONC
More ONC News >

ONC News on the Web

Baker Bros. Advisors LP Increases Stake in Celcuity Inc.
GuruFocus News
Neutral
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
TipRanks News
Bullish
BeOne Medicines initiated with an Outperform at Wolfe Research
TipRanks News
Bullish
BeOne Medicines Advances Combo Cancer Pill With Completed Phase 1 Bioavailability Study
TipRanks News
Bullish
Why Onconetix Stock Is Surging Before Reverse Split
TipRanks News
Neutral
BeOne Medicine (ONC) Gains FDA Orphan Drug Status for Liver Cancer Treatment
GuruFocus News
Bullish
BeOne Medicines treatment of hepatocellular carcinoma granted orphan designation
TipRanks News
Bullish
BeOne Medicines Advances BG-A3004 Into First-in-Human Skin Disease Trial: What Investors Should Watch
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
ONC
Sector Average
Media Buzz
This Week1 articles
Weekly Average4 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ONC’s Media Buzz Sentiment?
1 articles about ONC were published this week. In an average week, 4 articles are published.
    What is ONC’s weekly average amount of articles?
    In an average week, 4 articles about ONC are published.
      What is ONC’s News Sentiment?
      50% of articles about ONC were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        OMEROmeros
        AGIOAgios Pharma
        2273Gushengtang Holdings Limited
        PALIPalisade Bio
        LTRNLantern Pharma
        Showing the stocks with the most bullish news sentiment over the past week